Literature DB >> 9685586

Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine.

P J Currie1, D V Coscina, P J Fletcher.   

Abstract

Drugs that enhance serotonergic neurotransmission reduce food intake by directly or indirectly activating serotonergic receptors. In contrast drugs that inhibit serotonergic neurotransmission such as the 5-HT1A agonist 8-hydroxy-2-(di-n-propyl-amino)tetralin (8-OH-DPAT) stimulate food intake. The present study examined the effects of 8-OH-DPAT on the feeding suppressant action of the indirect 5-HT agonists fenfluramine (FEN; 0.63-2.5 mg/kg) and fluoxetine (FLU; 2.5-10 mg/kg), as well as the 5-HT1B/2C agonist 1-(3-trifluoromethylphenyl)piperazine (TFMPP; 0.5-2 mg/kg). 8-OH-DPAT (62.5-250 microg/kg) was administered 5 min prior to FEN, FLU or TFMPP, injected 30 min before food access. While FEN, FLU and TFMPP dose-dependently reduced 2 h food intake, 8-OH-DPAT stimulated eating behavior. 8-OH-DPAT (62.5-250 microg/kg) pretreatment reversed the anorectic action of FEN (1.25 mg/kg) and FLU (5 mg/kg) but not TFMPP (1 mg/kg). Separate groups of rats were injected with 5,7-dihydroxytryptamine (5,7-DHT; 3 microg free base) into both the dorsal and median raphe, which resulted in extensive 5-HT depletion in hypothalamus (80%), striatum and hippocampus (90%). In both 5, 7-DHT and vehicle-injected rats, FEN (1.25 mg/kg) and FLU (5 mg/kg) suppressed feeding. In 5,7-DHT treated rats, however, the ability of 8-OH-DPAT (125 microg/kg) to block FEN and FLU induced anorexia was attenuated. That is, 8-OH-DPAT pretreatment did not reverse the feeding inhibitory effects of either FEN or FLU. Further, the ability of FEN and FLU to suppress food intake was not altered by the 5,7-DHT lesion. These findings suggest that the reversal of FEN and FLU anorexia by 8-OH-DPAT is partially dependent on the integrity of brain 5-HT systems since their disruption compromises the ability of this 5-HT1A agonist to antagonize the feeding suppressant action of either FEN or FLU. However, the ability of treatments which impair 5-HT neurotransmission to reverse FEN and FLU induced suppression of food intake may depend upon whether this impairment is acute and reversible (8-OH-DPAT), or chronic and irreversible (5,7-DHT). Copyright 1998 Published by Elsevier Science B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9685586     DOI: 10.1016/s0006-8993(98)00497-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Fluoxetine prevents 8-OH-DPAT-induced hyperphagia in Fischer inbred rats.

Authors:  Chandra Suma Johnson Miryala; Navin Maswood; Lynda Uphouse
Journal:  Pharmacol Biochem Behav       Date:  2011-01-28       Impact factor: 3.533

2.  Hypophagia and induction of serotonin transporter gene expression in raphe nuclei of male and female rats after short-term fluoxetine treatment.

Authors:  Nuria Lauzurica; Luis García-García; José A Fuentes; Mercedes Delgado
Journal:  J Physiol Biochem       Date:  2012-06-23       Impact factor: 4.158

3.  Effects of fenfluramine on free-operant timing behaviour: evidence for involvement of 5-HT2A receptors.

Authors:  S Body; S Kheramin; M-Y Ho; F Miranda Herrera; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  2004-04-22       Impact factor: 4.530

4.  Effects of 8-OH-DPAT and WAY-100635 on performance on a time-constrained progressive-ratio schedule.

Authors:  M-Y Ho; S Body; S Kheramin; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  2003-03-25       Impact factor: 4.530

5.  Sex differences in the reversal of fluoxetine-induced anorexia following raphe injections of 8-OH-DPAT.

Authors:  Paul J Currie; Melissa Braver; Aaisha Mirza; Krisna Sricharoon
Journal:  Psychopharmacology (Berl)       Date:  2003-11-28       Impact factor: 4.530

6.  Anxiolytic profile of fluoxetine as monitored following repeated administration in animal rat model of chronic mild stress.

Authors:  Muhammad Farhan; Darakshan Jabeen Haleem
Journal:  Saudi Pharm J       Date:  2015-03-20       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.